There’s one kind of tumor that’s basically straight out of a horror movie... Hosted by: Olivia Gordon SciShow has a spinoff ...

The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a promising way to improve existing cancer therapies ...

Fears about cell phones causing cancer persist despite scientific evidence to the contrary, with Health Secretary Robert F. Kennedy Jr. announcing a new investigation. Here’s what we know.

In a study published in the Journal of Extracellular Vesicles, scientists from the UF Health Cancer Institute have found a way to make treatment for a notoriously aggressive breast cancer more ...

NEW YORK – Neok Bio on Thursday said it has been cleared by the US Food and Drug Administration to begin a Phase I trial of its bispecific antibody-drug conjugate (ADC) NEOK001 in solid tumors.

A mysterious RNA molecule found only in breast cancer led researchers on a six-year hunt that uncovered an entire hidden layer of cancer biology. The story began with T3p, a tiny RNA molecule found in ...

Scientists have described a novel, yet benign bone-covered growth's characteristics for doctors, so patients don't receive ...

Louisville, Ky.-based UofL Health has become the first health system in the state to treat a patient using histotripsy, a ...

Editing CAR T cells to produce inflammatory cytokines helps them enter solid tumors and promote cancer killing.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

Due to the “programmable” nature of the nanoparticle, researchers are able to “swap out the antibodies or the drugs to target different diseases — like autoimmune disorders or different types of ...

The field of oncology has witnessed remarkable progress in the treatment of solid tumors, yet the quest for optimal therapeutic outcomes remains a formidable challenge. Current clinical evidence ...